Childhood PancreatitisSymptoms, Doctors, Treatments, Advances & More
Learn About Childhood Pancreatitis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
BIDMC - Division Of Gastroenterology/GI East
Steven Freedman is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Freedman is rated as an Elite provider by MediFind in the treatment of Childhood Pancreatitis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Exocrine Pancreatic Insufficiency, Hereditary Pancreatitis, Chronic Pancreatitis, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Freedman is board certified in American Board Of Internal Medicine.
UT Southwestern - Pediatric Gastroenterology
Bradley Barth is a Pediatric Gastroenterologist and a Pediatrics provider practicing medicine in Dallas, Texas. Dr. Barth is rated as an Elite provider by MediFind in the treatment of Childhood Pancreatitis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Childhood Pancreatitis, Chronic Pancreatitis, Hereditary Pancreatitis, Endoscopy, and Gallbladder Removal.
Pediatric Gastroenterology
John Pohl is a Pediatric Gastroenterologist practicing medicine in Salt Lake City, Utah. Dr. Pohl is rated as an Elite provider by MediFind in the treatment of Childhood Pancreatitis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Childhood Pancreatitis, Chronic Pancreatitis, Hereditary Pancreatitis, Endoscopy, and Gastrostomy. Dr. Pohl is board certified in American Board Of Pediatrics. Dr. Pohl is currently accepting new patients.
Summary: This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer. Finding genetic markers among pediatric patients with acute recurrent pancreatitis and chronic pancreatitis may help identify patients who are at risk of pancreatic cancer.
Summary: This is a phase I/II clinical trial assessing the tolerability and efficacy of CM4620 in children and young adults with acute pancreatitis caused by asparaginase. The tolerability of CM4620 when given to patients receiving frontline chemotherapy will be determined. The effectiveness in reducing the severity of pancreatitis will be estimated. Primary Objectives To assess the safety of CM4620 admini...